March marks Colorectal Cancer Awareness Month, with the aim of raising awareness of the third most common cancer and the ...
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
According to Research by SNS Insider, The Lancet Market Growth is Driven by Growing Demand for Home Diagnostics and Safety Lancets.Pune, March 14, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, ...
A study published in Lancet HIV Thursday showed that patients who received gender-affirming hormones were 37% less likely to ...
Managing blood sugar levels is essential for overall health, especially for those with diabetes or insulin resistance. Here ...
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...
Decades of research and news articles espousing an “obesity epidemic” and tons of weight-loss products launched under the ...
3h
News-Medical.Net on MSNGender affirming hormone therapy reduces HIV risk for transgender peopleTransgender people receiving gender-affirming hormone therapy have a 37% lower chance of acquiring HIV, and for people living ...
SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.
7d
Verywell Health on MSNMounjaro vs. Trulicity: How Do They Compare for Type 2 Diabetes?Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...
Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them could blunt that trend — if people can get them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results